The American Diabetes Association’s Innovation Fund Invests In UpDoc To Accelerate The Future Of AI-Driven Chronic Disease Management & Prevention

The American Diabetes Association (ADA) announced a strategic investment in UpDoc, a clinical artificial intelligence (AI) company focused on chronic disease management, through its Innovation Fund. The fund's investment in UpDoc reflects its view that clinical AI, deployed responsibly and at scale, can help close the gap between the care need and the care received.

In addition to capital, the ADA will contribute clinical and research expertise intended to support UpDoc's product development and commercial adoption.

UpDoc's platform combines agentic AI with health care professional oversight to support ongoing chronic disease management between scheduled visits. The company . . .